As such, ghrelin and its analogs might offer potential to treat cachexia (25, 26), sarcopenia (27), myopenia (28), gastroparesis (29), or anorexia nervosa (26) whereas inhibition of ghrelin signaling might offer potential to treat obesity and diabetes (30). The gene discussed is GHRL; the disease is sarcopenia.